CJ, Alteogen sign MOU on human GH research

Published: 2010-07-14 06:56:00

Updated: 2010-07-14 06:56:00

CJ Cheil Jedang and Alteogen Inc., a local biopharmaceutical firm signed a memorandum of understanding on July 9 to collaborate on joint projects and on the research and development of a novel human growth hormone (GH).

Both companies agreed to conduct a joint project to develop a weekly-dose,...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK